NuGene Pharma (Shandong) CMO Services

Core Competitiveness and Strategic Value of NuGene Pharma (Shandong) CMO ServicesCorporate Positioning & Strategic LayoutHistorical Evolution & Ownership ChangeFormerly Meiji Pharmaceuticals (Japanese-funded)
Fully acquired by Hengkang Pharmaceutical in 2022
Strategic Positioning & Business DirectionSpecializing in Microbial Fermentation CMO
Synthetic Biology Innovation Platform
Providing Integrated Solutions for Cross-disciplinary Fields
Core Technologies & Management SystemHardcore Capability: Zero Contamination RecordSystematic Assurance Program
Eliminating the Primary Risk of Production Failure
Hardware Infrastructure AssuranceInternational-brand Fermentation Systems
Fully Automated Cleaning & Sterilization (CIP/SIP)
Redundant Compressed Air System
Stringent Quality Management SystemImplementing Japanese cGMP Standards
Rigorous Control of Cleanroom Environment
Dedicated Quality Control Laboratory
Integration of Technology & CultureComprehensive Aseptic Operation Training for All Staff
Highly Experienced Core Team
Proactive Risk Assessment Capability
End-to-End Services & Industrial EmpowermentAccelerating Lab-to-Market TranslationCollaboration Case with Academician Huang He’s Team
Efficient Industry-Academia-Research Commercialization
One-Stop End-to-End ServiceCovering R&D, Manufacturing, and Commercialization
Leveraging Parent Company’s Global Network: 70+ Countries, 400+ International Clients
Reducing Client’s Operational Complexity
Ensuring Supply Chain SecurityHigh Success Rate & Stable Delivery Performance
Supporting Both Clinical and Commercial Stages
Strategic Partnership Value & Ecosystem RoleClient Value CreationEnabling Complementary Strengths: Focus on Production & Global Sales
Reducing Investment & Operational Risks
Shortening Product Development Timelines
Industry Role DefinitionTranscending Traditional CMO Boundaries
Becoming a Critical Enabler for Industrialization
Co-building the New Bio-manufacturing Ecosystem
Scroll to Top